Fisetin inhibits the growth and migration in the A549 human lung cancer cell line via the ERK1/2 pathwayJunjian Wang(Sun Yat-sen University), Shangxiang Huang(Tianjin Central Hospital of Gynecology Obstetrics)Experimental and Therapeutic MedicineDecember 21, 201710.3892/etm.2017.5666Cited by 47SaveCiteExport RISWatch citationsRelated PapersTumor mitochondrial oxidative phosphorylation stimulated by the nuclear receptor RORγ represents an effective therapeutic opportunity in osteosarcoma|Cell Reports Medicine|2024|17Targeting RORγ inhibits the growth and metastasis of hepatocellular carcinoma|Molecular Therapy|2024|14The novel indomethacin derivative CZ-212-3 exerts antitumor effects on castration-resistant prostate cancer by degrading androgen receptor and its variants|Acta Pharmacologica Sinica|2021|8